Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Original Source
Read the full article at Gizmodo →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.